Condition
Mid-portion Achilles Tendinopathy
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06969859Not ApplicableRecruitingPrimary
Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy
NCT06774066Not ApplicableCompletedPrimary
High Volume Injection in Mid Portion AChilles Tendinopathy
NCT00835939Phase 2Unknown
Treatment for Achilles Tendinopathy
Showing all 3 trials